Caroline
Analyst
Seagull
Equibles does not estimate personal net worth.
About Caroline
Caroline is recorded as Analyst at Seagull. Caroline has spoken on 1 earnings call across 1 company, most recently for Rigel Pharmaceuticals Inc on November 5, 2026. The companies whose calls Caroline spoke on are classified in the Healthcare sector.
Caroline on recent calls
“Can you help us understand how much of Vepinew's $6.6 million in sales reflected initial channel inventory stocking versus underlying patient demand? And what are October trends looking like?”
Affiliation history
-
Seagull
Analyst
Transcript header (unverified)
Current